Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 46, pseudogene (RNU1-46P) is a pseudogene in the human genome that resembles the genes encoding U1 small nuclear RNAs (snRNAs), which are essential RNA components of the spliceosome complex responsible for pre-mRNA splicing[1][3][6][7]. However, RNU1-46P itself is classified as a pseudogene—meaning it does not encode a functional RNA product and is generally considered non-functional for biological processes. It is not a known therapeutic target, does not have established biological or disease roles, and should not be considered an active molecular target for drug development or biomarker strategies[1][6]. Its main value may be in genome annotation and evolutionary studies rather than in functional biology or medicine. Key clarifications: - RNU1-46P is a pseudogene and does not produce a functional small nuclear RNA[1][6][7]. - It is not considered a therapeutic target, receptor, enzyme, transporter, or any of the commonly druggable target classes. - No associated drugs, mechanism of action, biomarkers, safety concerns, or disease relevance have been reported. - A similar name, RNU1-1, refers to the functional U1 snRNA gene family, but RNU1-46P specifically designates the non-functional (pseudogene) member[3][6][7]. If you are seeking information about the **functional** U1 small nuclear RNA (e.g., "RNA, U1 small nuclear 1"), refer to gene RNU1-1 instead, which is crucial for mRNA splicing, but this does not apply to RNU1-46P[2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 46, pseudogene (RNU1-46P).